open access

Vol 6, No 3 (2013)
REVIEWS
Get Citation

Selected RhD topics presented during the 23rd Regional Congress of the International Society of Blood Transfusion in Amsterdam

Monika Pelc-Kłopotowska, Ewa Brojer
Journal of Transfusion Medicine 2013;6(3):105-108.

open access

Vol 6, No 3 (2013)
REVIEWS

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Selected RhD topics presented during the 23rd Regional Congress of the International Society of Blood Transfusion in Amsterdam

Journal

Journal of Transfusion Medicine

Issue

Vol 6, No 3 (2013)

Pages

105-108

Bibliographic record

Journal of Transfusion Medicine 2013;6(3):105-108.

Authors

Monika Pelc-Kłopotowska
Ewa Brojer

References (15)
  1. Wagner F. RhesusBase v2: a versatile source of information on published RHD alleles. Vox Sang. 2013; 105(supl. 1): 1–64.
  2. Meshi A. Characterisation of antigenicity of an RhD peptide mimotope and assessment of its immunogenicity in HLA-DR15 transgenic mice. Vox Sang. 2013; 105(supl. 1): 1–64.
  3. Hall S, Hall M, Pickford J, et al. Combination peptide immunotherapy suppresses antibody and helper T cell responses to the RhD protein in HLA-transgenic mice. Vox Sang. 2013; 105(supl. 1): 65–299.
  4. Hall AM, Cairns LS, Altmann DM, et al. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood. 2005; 105(5): 2175–2179.
  5. Tan JC, Armstrong NJ, Yuan FF, et al. Genetic polymorphisms and immune response pathways associated with different responder profiles of RhD immunized blood donors. Vox Sang. 2013; 105(supl. 1): 1–64.
  6. Verduin EP, Schonewille H, Claas F, et al. HLA-DRB1*15 is a marker for multiple antibody responders. Vox Sang. 2013; 105(supl. 1): 1–64.
  7. Hong YJ, Chang HE, Hwang SM, et al. Molecular characteristics of partial D in Korea. Vox Sang. 2013; 105(supl. 1): 65–299.
  8. Silvy M, Granier T, Beley S, et al. First comprehensive investigation of both RHD and RHCE allele distribution in Sub-Saharan Africa: the clinical implications for transfusion medicine. Vox Sang. 2013; 105(supl. 1): 65–299.
  9. Hyland A, Gardener J, et al. O’Brien H. Managing diverse maternal RHD variants in alloimmunised and non-alloimmunised D negative pregnant women during fetal RHD genotyping. Vox Sang. 2013; 105(supl. 1): 1–64.
  10. Trucco Boggione C, Lujan Brajovich M, Tarrago M, et al. Molecular structures identified in serologically D negative samples of an admixed population. Vox Sang. 2013; 105(supl. 1): 1–64.
  11. Veldhuisen B, Thurik F, Jonkers R, et al. Molecular RHD variation of serological RhD negative women: implications for a fetal RHD screening programme to target anti-D prophylaxis. Vox Sang. 2013; 105(supl. 1): 1–64.
  12. Pisacka M, Sklenarova M, Kralova M, et al. VII: the most frequent partial D in Czech population with ‘Hidden Iceberg” real incidence: Results of a proficiency survey and D Variant Database in UHKT. Vox Sang. 2013; 105(supl. 1): 65–299.
  13. Figueiredo M, Chumakova A, Pereira J, et al. Being positive can be negative identification of a partial DIIIc. Vox Sang. 2013; 105(supl. 1): 65–299.
  14. Polin H, Ulrich S, Lanzer G, et al. RHD*WEAK D type 48 is prevalent in Southern Austria. Vox Sang. 2013; 105(supl. 1): 65–299.
  15. Castilho L, Machado D, Torres KB, et al. Jr. Anti-D in patients expressing weak D type 2. Vox Sang. 2013; 105(supl. 1): 65–299.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl